Electromyography Devices Market Expected to Reach $1.7 Billion by 2031

Electromyography devices market size was valued at $786.0 million in 2021, and is estimated to reach $1,648.7 billion by 2031, growing at a CAGR of 7.9% from 2022 to 2031. Electromyography (EMG) determines electrical activity or muscle response by responding to muscle stimulation. Neuromuscular abnormalities can be detected using EMG which assists in the diagnostic process. During testing, one or more small electrodes are inserted through the skin into the muscles. The electrical activity captured by the electrodes is also reflected in a monitor that shows the same electrical activity in the form of waves. A sound amplifier is used to hear the work.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
muscular dystrophies, distal myopathies, congenital myopathies, myotonic dystrophy, myotonia congenita, primary periodic paralysis, inflammatory muscle diseases

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/15187

Growth of the electromyography devices market share is majorly driven by a surge in the geriatric population that is more vulnerable to neurological and muscular diseases, advancements of biofeedback equipment, rise in the prevalence of muscular disorders such as Alzheimer's disease, Parkinson's disease, migraine and Huntington's disease.

For instance, according to the World Health Organization in 2021, between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. In 2050, 80% of older people will be living in low- and middle-income countries. According to Alzheimer's Society, it is estimated that about 5.8 million people in the U.S. aged 65 years and above were affected by Alzheimer's dementia in 2020. Hence, such factors propel the growth of the EMG devices market.

𝐁𝐮𝐲 𝐍𝐨𝐰 https://www.alliedmarketresearch.com/checkout-final/02c395b793d4eb9f1d6c78d5eb7be1c2

On the basis of study type, the nerve conduction segment is expected to witness the highest CAGR during the forecast period, owing to an increase in investment in research studies, and an increase in the use of nerve conduction studies. Growth of the nerve conduction segment is also associated with an increase in cases of sciatic nerve problems, and chronic inflammatory polyneuropathy, which leads to an increase in the use of nerve conduction study for diagnosis it and boost the growth of the nerve conduction segment

On the basis of end-user, the clinic's segment is expected to witness the highest CAGR during the forecast period, owing to an increase in discounted rates for patients, an increase in the geriatric population that are more prone to neuromuscular disease, and an increase in a number of Alzheimer and Parkinson diseases and increase in a number of patients visits in clinics. The rise in healthcare expenditure also boosts the growth of the clinic's segment in the electromyography devices market.

Asia-Pacific is expected to witness the highest CAGR during the forecast period, owing to a surge in geriatric populations that are more prone to neuromuscular diseases, a rise in awareness regarding the use of portable electromyography devices for diagnosis of neuromuscular diseases, unmet medical demands, and increase in public-private investments in the healthcare sector.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/15187

𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘

On the basis of product, the stationary EMG systems segment held the largest share of the electromyography devices market in 2021.

By study type, the nerve conduction segment held the largest share of the electromyography devices market in 2021.

The report includes an analysis of the regional as well as global Electromyography Devices Market Trends, key players, market segments, application areas, and Electromyography Devices Market Growth strategies.

On the basis of end-user, the hospital's segment held the largest market share in 2021 in the Electromyography Devices Industry.

On the basis of region, North America held the largest market share in 2021.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.